Date Title Alternative
2024-03-01 Coverage paused Download | Show Close
2024-01-31 Volume update on UK project Download | Show Close
2023-11-15 Guidance reiterated, but with reduced visibility Show Close
2023-10-04 A new deal Show Close
2023-08-15 Full-year guidance suggests growth has returned Show Close
2023-05-15 Working through 2022 order book Show Close
2023-02-28 Order book shows growth returning Show Close
Research | 28 Feb 2023 | Irisity

Order book shows growth returning

 

Report in line with the profit warning and liquidity update

Net sales in the quarter totalled SEK 12.5m, in line with the company’s profit warning, and represented growth of -65%. Turnover was burdened by delays and deliveries that have been postponed past year-end. At the time of the profit warning, the company presented its order book for the first time. This now amounts to SEK 45m and is expected to be delivered in H1 2023. EBITDA in the quarter was SEK -14.4m. Available cash was at SEK 44m in January, and the company saw positive operating cash flows in January and February.

View on tech unchanged, but uncertainty regarding delivery capacity

We have high confidence in Irisity’s technology, since the company has received technical validation from several key players in the ecosystem. In Q4, it signed two framework agreements with leading players. Moreover, we see that industry interest in software investments facilitating surveillance work is considerable. At present, however, Irisity has had repeated problems in delivering projects. We believe part of this stems from it winning larger and more complex projects for which it lacks the delivery capacity. As the company has invested in supply capacity to address these problems during Q4 and early this year, we believe there is potential for it to return to growth in the near future.

 

Estimates remain cautious

Given the profit warning, we lower our sales estimates by 14% for 2023 and 11% for 2024. For the current year, we expect the stated order book to be achieved and that MRR will provide the basis for sales. We expect the company to return to positive cash flows thanks to the cash currently at its disposal. Given the uncertainty, we reiterate our fair value of SEK 7.3–8.0. We believe the order book needs to start being realised before we can adjust this.

 

2022-11-15 Most challenges lie ahead Show Close
2022-08-17 Organic growth accelerates Show Close
2022-05-25 Capital Market Day sets the pace going forward Show Close
2022-02-21 MRR growth and gross margin reach record highs Show Close
2021-08-09 Accelerating growth Show Close
2021-05-10 In line with our expectations and confirms commercialization plan Show Close